A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)

NCT06287528 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Philadelphia-Negative ALL
Philadelphia-Positive ALL
Relapsed ALL, Adult
Refractory Acute Lymphoblastic Leukemia
Refractory Acute Lymphoblastic Leukemia (ALL)
Refractory Acute Lymphoid Leukemia in Relapse

Interventions

BIOLOGICAL: 19-28z/IL-18 CAR T cells

Sponsor

Memorial Sloan Kettering Cancer Center